2000
DOI: 10.1161/01.cir.102.22.2707
|View full text |Cite
|
Sign up to set email alerts
|

In Vivo and In Vitro Evidence for Impaired Arginine Transport in Human Heart Failure

Abstract: Background-The clinical features of congestive heart failure (CHF) result from a complex interaction between reduced ventricular function, neurohormonal activation, and impaired endothelial function. Although endothelial dysfunction has been well documented, the mechanisms that contribute to this abnormality remain unknown. Recent studies, however, indicate a potential therapeutic role for supplemental L-arginine, suggesting the presence of an underlying disorder of L-arginine metabolism. Methods and Results-W… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
58
1
1

Year Published

2002
2002
2020
2020

Publication Types

Select...
6
4

Relationship

3
7

Authors

Journals

citations
Cited by 64 publications
(65 citation statements)
references
References 53 publications
5
58
1
1
Order By: Relevance
“…In a similar manner, we have shown previously that CAT1 mRNA is significantly decreased in association with decreased arginine uptake in heart failure patients. 29 The rapid actions of CSE suggest a posttranslational modification of CAT1, possibly involving 1 or more cysteine residues given the ability of N-acetyl cysteine to attenuate the effects of CSE and DTNB, a dithiol oxidizing agent, to mimic the actions of CSE. To our knowledge, however, this potential posttranslational mechanism for the regulation of CAT1 has not been reported previously.…”
Section: Discussionmentioning
confidence: 99%
“…In a similar manner, we have shown previously that CAT1 mRNA is significantly decreased in association with decreased arginine uptake in heart failure patients. 29 The rapid actions of CSE suggest a posttranslational modification of CAT1, possibly involving 1 or more cysteine residues given the ability of N-acetyl cysteine to attenuate the effects of CSE and DTNB, a dithiol oxidizing agent, to mimic the actions of CSE. To our knowledge, however, this potential posttranslational mechanism for the regulation of CAT1 has not been reported previously.…”
Section: Discussionmentioning
confidence: 99%
“…7 In brief, peripheral blood mononuclear cells were incubated in a balanced salt solution with L-arginine in concentrations ranging from 1 to 300 mol/L, incorporating 100 nmol/L [ 3 H]-L-arginine for a period of 5 minutes at 37°C. Uptake was terminated by 3 successive cell pellet washes in ice-cold KrebsHenseleit buffer.…”
Section: Study Protocol For Investigation Of L-arginine Uptake In Permentioning
confidence: 99%
“…41 An FMD measurement for the purpose of perioperative risk stratification was assessed in a study of 187 patients undergoing high-risk (vascular) surgery. Low flow-mediated dilation was an independent predictor of a cardiac event at 30 days (odds ratio 9) 41 and of late events at 1.2-year follow-up.…”
Section: 80mentioning
confidence: 99%